Description
Teoxane Teosyal RHA Kiss (2×0,7ml)
Teosyal® RHA Kiss is a CE‑marked hyaluronic acid (HA) dermal filler designed for professional aesthetic use in lip augmentation, contour refinement, and correction of fine perioral lines. Utilising patented RHA® (Resilient Hyaluronic Acid) technology, the gel comprises 23 mg/mL cross‑linked HA of non‑animal origin and 0.3 % lidocaine hydrochloride to enhance comfort during injection. RHA technology is engineered to preserve longer HA polymer chains with resilience and elasticity, making it suited for dynamic mobile regions like the lips, where natural movement is important. The viscoelastic properties support soft volume enhancement and improved lip definition while accommodating facial motion. RHA Kiss is indicated for adding subtle dynamic volume and smoothing perioral wrinkles such as “barcode” lines. Its effects are typically observed immediately with ongoing hydration, and clinical data suggest durations of approximately 6–8 months depending on individual metabolism, injection technique, and anatomical considerations.
What Teosyal® RHA Kiss Is Similar To
Teosyal® RHA Kiss is comparable to other lip‑oriented HA dermal fillers such as Restylane® Kysse and Juvederm® Volbella XC, which are designed to add subtle volume and refine lip contours while addressing perioral fine lines. Like these products, RHA Kiss uses cross‑linked hyaluronic acid to attract and retain water in tissues, enhancing hydration and structure. The distinguishing feature of RHA Kiss is its resilient HA network, intended to maintain elasticity in dynamic regions like lips and perioral zones. Both Restylane Kysse and Juvederm Volbella also balance volume with flexibility, but differences in HA concentration, particle size, cross‑linking, and rheologic behaviour can influence lift capacity and integration under motion. Longevity for these lip fillers is generally in the 6–9 month range, subject to metabolic and anatomical factors. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
-
Lip volume enhancement (mucosal tissue)
-
Lip contour definition and symmetry refinement
-
Correction of fine perioral wrinkles (“barcode” lines)
Treatment areas per manufacturer/distributor information.
Usage / Administration (IFU‑Only Section)
Only use data directly supported by official product documentation. Where items are not stated in the publicly available IFU, this is noted.
-
Injection depth:
-
Lip mucosa for volume and vermilion enhancement
-
Mid‑dermis for perioral fine lines
-
-
Volume per point / injection site: Not provided by manufacturer
-
Needle gauge: 30G × ½″ sterile needles included in packaging
-
Frequency / number of sessions: Not provided by manufacturer
-
Professional‑use disclaimer: Administered only by qualified medical professionals under aseptic conditions
Some clinicians may use specific layering or micro‑linear techniques for perioral lines; such approaches are not part of the official manufacturer guidance.
Ingredient List
-
Hyaluronic Acid (HA): 23 mg/mL cross‑linked RHA of non‑animal origin
-
Lidocaine Hydrochloride: 0.3 % for procedural comfort
-
Phosphate Buffer (pH 7.3): stabilising excipient
Presentation & Longevity
-
Packaging: 2 × 0.7 ml pre‑filled syringes, 2 × 30G × ½″ needles, traceability labels, product insert
-
Shelf life: Not provided by manufacturer
-
Treatment duration: ≈6–8 months, variable by individual factors
Safety Notes / Contraindications
-
Hypersensitivity: Contraindicated in individuals with known hypersensitivity to HA, lidocaine, or any component of the formulation.
-
Active conditions: Avoid injection in areas of active infection, inflammation, or compromised tissue integrity.
-
Pregnancy / breastfeeding: Contraindicated, as with many HA fillers, unless otherwise authorised in local IFU.
-
Allergy caution: Prior allergy assessment is recommended for patients with a history of hypersensitivity reactions.
Regulatory Status
-
CE‑marked Class III medical device under EU Medical Device Regulation (MDR).
-
Regulatory classification not specified in public documentation; verify on product pack or manufacturer IFU.
FAQ
1. What is Teosyal® RHA Kiss?
Teosyal® RHA Kiss is a resilient hyaluronic acid dermal filler formulated to enhance lip volume, redefine lip contours, and improve fine perioral lines. It utilises RHA® technology, combining elastic cross‑linked HA (23 mg/mL) with 0.3 % lidocaine to support dynamic movement and patient comfort during injection by trained professionals.
2. How does RHA Kiss work?
The product works by increasing volume and hydration within lip and perioral tissues through HA’s capacity to retain water. Its resilient cross‑linked structure is designed to adapt to movement, providing flexibility and natural integration in mobile facial zones.
3. Where is RHA Kiss indicated?
According to available product data, RHA Kiss is indicated for lip mucosal augmentation, lip contour refinement, and correction of fine perioral wrinkles (“barcode” lines). Injection depth varies by target tissue, with mucosal placement for lips and mid‑dermal for perioral lines.
4. How long do results last?
Distributor and product literature suggests that results from Teosyal® RHA Kiss typically persist around 6–8 months, influenced by individual metabolism, anatomy, and injection technique.
5. Is RHA Kiss safe?
When administered by trained clinicians following aseptic technique and proper patient assessment, RHA Kiss is generally well tolerated. As with all HA fillers, transient reactions like mild swelling, redness, or tenderness may occur. Contraindications include known component hypersensitivity and active infection at the treatment site.
